BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26869462)

  • 1. Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients.
    Bianco M; Gasparri AM; Colombo B; Curnis F; Girlanda S; Ponzoni M; Bertilaccio MT; Calcinotto A; Sacchi A; Ferrero E; Ferrarini M; Chesi M; Bergsagel PL; Bellone M; Tonon G; Ciceri F; Marcatti M; Caligaris-Cappio F; Corti A
    Cancer Res; 2016 Apr; 76(7):1781-91. PubMed ID: 26869462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
    Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of tumor growth by circulating full-length chromogranin A.
    Curnis F; Dallatomasina A; Bianco M; Gasparri A; Sacchi A; Colombo B; Fiocchi M; Perani L; Venturini M; Tacchetti C; Sen S; Borges R; Dondossola E; Esposito A; Mahata SK; Corti A
    Oncotarget; 2016 Nov; 7(45):72716-72732. PubMed ID: 27683038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models.
    Bianco M; Gasparri A; Generoso L; Assi E; Colombo B; Scarfò L; Bertilaccio MT; Scielzo C; Ranghetti P; Dondossola E; Ponzoni M; Caligaris-Cappio F; Ghia P; Corti A
    Oncotarget; 2016 Jul; 7(27):41725-41736. PubMed ID: 27203389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatiotemporal Regulation of Tumor Angiogenesis by Circulating Chromogranin A Cleavage and Neuropilin-1 Engagement.
    Dallatomasina A; Gasparri AM; Colombo B; Sacchi A; Bianco M; Daniele T; Esposito A; Pastorino F; Ponzoni M; Marcucci F; Curnis F; Corti A
    Cancer Res; 2019 Apr; 79(8):1925-1937. PubMed ID: 30796053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new chromogranin A-dependent angiogenic switch activated by thrombin.
    Crippa L; Bianco M; Colombo B; Gasparri AM; Ferrero E; Loh YP; Curnis F; Corti A
    Blood; 2013 Jan; 121(2):392-402. PubMed ID: 23190532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral shRNA silencing of BDNF inhibits in vivo multiple myeloma growth and angiogenesis via down-regulated stroma-derived VEGF expression in the bone marrow milieu.
    Zhang L; Hu Y; Sun CY; Li J; Guo T; Huang J; Chu ZB
    Cancer Sci; 2010 May; 101(5):1117-24. PubMed ID: 20331634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of Syndecan-1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis.
    Andersen NF; Kristensen IB; Preiss BS; Christensen JH; Abildgaard N
    Eur J Haematol; 2015 Sep; 95(3):211-7. PubMed ID: 25353275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow angiogenesis and circulating plasma cells in multiple myeloma.
    Kumar S; Witzig TE; Greipp PR; Rajkumar SV
    Br J Haematol; 2003 Jul; 122(2):272-4. PubMed ID: 12846897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression.
    Wang J; De Veirman K; Faict S; Frassanito MA; Ribatti D; Vacca A; Menu E
    J Pathol; 2016 Jun; 239(2):162-73. PubMed ID: 26956697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High heparanase activity in multiple myeloma is associated with elevated microvessel density.
    Kelly T; Miao HQ; Yang Y; Navarro E; Kussie P; Huang Y; MacLeod V; Casciano J; Joseph L; Zhan F; Zangari M; Barlogie B; Shaughnessy J; Sanderson RD
    Cancer Res; 2003 Dec; 63(24):8749-56. PubMed ID: 14695190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis in multiple myeloma.
    Jakob C; Sterz J; Zavrski I; Heider U; Kleeberg L; Fleissner C; Kaiser M; Sezer O
    Eur J Cancer; 2006 Jul; 42(11):1581-90. PubMed ID: 16797965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse prognostic impact of bone marrow microvessel density in multiple myeloma.
    Lee N; Lee H; Moon SY; Sohn JY; Hwang SM; Yoon OJ; Youn HS; Eom HS; Kong SY
    Ann Lab Med; 2015 Nov; 35(6):563-9. PubMed ID: 26354343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma.
    Reni M; Andreasi V; Gasparri AM; Dugnani E; Colombo B; Macchini M; Bianco M; Dallatomasina A; Citro A; Assi E; Protti MP; Esposito A; Falconi M; Curnis F; Piemonti L; Corti A
    Front Oncol; 2020; 10():613582. PubMed ID: 33425767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.
    Du W; Hattori Y; Hashiguchi A; Kondoh K; Hozumi N; Ikeda Y; Sakamoto M; Hata J; Yamada T
    Pathol Int; 2004 May; 54(5):285-94. PubMed ID: 15086832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS; Kumar L; Dinda AK; Dawar R
    Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents.
    Cibeira MT; Rozman M; Segarra M; Lozano E; Rosiñol L; Cid MC; Filella X; Bladé J
    Cytokine; 2008 Mar; 41(3):244-53. PubMed ID: 18178097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
    Rajkumar SV; Mesa RA; Fonseca R; Schroeder G; Plevak MF; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Russell SJ; Greipp PR
    Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis in multiple myeloma.
    Vacca A; Ria R; Reale A; Ribatti D
    Chem Immunol Allergy; 2014; 99():180-96. PubMed ID: 24217610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of bone marrow angiogenesis in multiple myeloma].
    Tichý M; Tichá V; Scudla V; Sváchová M; Zapletalová J
    Cesk Patol; 2010 Jan; 46(1):15-9. PubMed ID: 21280277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.